Trevi Therapeutics Inc (TRVI)

EBITDA

-$51.04M

TTM · Period ending: · USD

TRVI logo

TRVI EBITDA

Latest reported-$51.04M
TRVI TTM EBITDA (-$20.02M → -$51.04M)
High-resolution chart · PNG

TRVI ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Trevi Therapeutics Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-51,040,000
-45,542,000
-42,678,000
-45,737,000
-47,194,000
-47,231,000
-47,791,000
-44,195,000
-38,632,000
-33,299,000
-28,583,000
-26,055,000
-26,354,000
-27,119,000
-27,982,000
-30,951,000
-29,916,000
-31,651,000
-32,709,000
-33,689,000
-33,980,000
-31,880,000
-32,273,000
-29,620,000
-29,751,000
-29,770,000
-26,101,000
-25,587,000
-23,903,000
-20,872,000
-20,020,000
-16,223,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.